Forbes India Magazine - February 2, 2018
In this issue
Novel drug discovery is a high risk, high return gambit. But those who had written off Biocon’s Kiran Mazumdar-Shaw and her tribe a decade ago may have sat up and noticed when her company’s biosimilar received approval to be marketed in the US recently. Innovation in healthtech today goes beyond drug discovery. In our cover story, we check out a variety of such deep-science ventures. Also in this issue, read about SoftBank’s ‘big is better (and safer)’ strategy. Elsewhere, in our pre-budget special package, we examine what to expect from the Union Budget.
Forbes India Magazine Description:
Publisher: Digital18
Category: Business
Language: English
Frequency: Fortnightly
Forbes is the world’s leading business magazine and since its inception in 1917, Forbes has stood, unwavering, for one overriding principle: the unshakable belief in the power of free enterprise.
Forbes mission has always been clear and unchanging: to provide insights and information that ensure the success of the world’s most influential. Faithfully fulfilling that promise is what draws today's most influential business leaders to Forbes. These high-powered decision-makers represent a community of like-minded individuals bound by their unshakable belief in the spirit of free enterprise. They contribute to it, profit from it and their lives are better for it. For them, Forbes is the quintessential Capitalist Tool.
True to its pedigree, Forbes India has donned on the role of the drama critic to Indian business. Since its launch in 2009, the magazine has helped readers connect the dots, form patterns and see beyond the obvious, giving them a perspective beyond the obvious.
- Cancel Anytime [ No Commitments ]
- Digital Only